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the colonic mucosa‑associated 
microbiome in SiV infection: shift 
towards Bacteroidetes coincides 
with mucosal  CD4+ t cell depletion 
and enterocyte damage
Kristina Allers1*, christiane Stahl‑Hennig2, tomas fiedler3, Daniel Wibberg4, Jörg Hofmann5, 
Désirée Kunkel1,6, Verena Moos1, Bernd Kreikemeyer3, Jörn Kalinowski4 & thomas Schneider5
The intesinal microbiome is considered important in human immunodeficiency virus (HIV) 
pathogenesis and therefore represents a potential therapeutic target to improve the patients’ 
health status. Longitudinal alterations in the colonic mucosa‑associated microbiome during simian 
immunodeficiency virus (SIV) infection were investigated using a 16S rRNA amplicon approach on the 
illumina sequencing platform and bioinformatics analyses. following SiV infection of six animals, no 
alterations in microbial composition were observed before the viral load peaked in the colon. At the 
time of acute mucosal SiV replication, the phylum Bacteroidetes including the Bacteroidia class as 
well as the phylum firmicutes and its families Ruminococcaceae and eubacteriaceae became more 
abundant. enrichment of Bacteroidetes was maintained until the chronic phase of SiV infection. the 
shift towards Bacteroidetes in the mucosa‑associated microbiome was associated with the extent of 
SIV infection-induced mucosal  CD4+ t cell depletion and correlated with increasing rates of enterocyte 
damage. These observations suggest that Bacteroidetes strains increase during virus-induced mucosal 
immune destruction. As Bacteroidetes belong to the lipopolysaccharide‑ and short chain fatty 
acids-producing bacteria, their rapid enrichment may contribute to inflammatory tissue damage and 
metabolic alterations in SiV/HiV infection. these aspects should be considered in future studies on 
therapeutic interventions.
Mucosal inflammation and impairment of the intestinal barrier are among the earliest events in human immuno-
deficiency virus (HIV)  infection1–3. Microbial translocations across the impaired intestinal barrier into circula-
tion are thought to trigger systemic immune activation, which drives HIV disease  progression4,5. Components 
of the intestinal microbiota produce factors that modulate epithelial growth and barrier function and regulate 
local immune  responses6. Consequently, changes in the microbial composition have often been linked to inflam-
mation and  disease7. In HIV and simian immunodeficiency virus (SIV) infections, alterations in the intestinal 
microbiota are thought to contribute to  pathogenesis4,8–12. However, the influence of the virus infection on the 
microbial composition remains poorly understood. Observational studies on HIV infection provide inconsistent 
results: in some lower diversity is  described10,13–15, while in others no change or an overall higher diversity than 
in HIV-negative controls were  observed8,11,16,17. Similarly, whereas several studies revealed a shift in the relative 
abundance from Bacteroides to Prevotella or vice versa8,10,11,14,17, others did not note a difference in these genera 
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of the phylum  Bacteroidetes13,16. Possible reasons for such contradictory results may include the cross-sectional 
study design, particularly in light of recent studies that suggest that the abundance of Bacteroides and Prevotella 
depends on sexual practice and lifestyle or nutrition rather than HIV  infection15,18,19. Cross-sectional studies may 
not be suitable to provide information about cause-and-effect relationships, whereas longitudinal ones could be 
more valid for examining such relationships.
Data collected over a longer period of time are mainly derived from non-human primates (NHPs). How-
ever, all of these NHP studies used fecal samples for analysis, and tissue samples have never been analyzed 
 longitudinally20–23. Nevertheless, with respect to immune pathogenesis, the more conserved mucosa-associated 
microbial compartment might be more important as it interacts with the mucosal immune system and resists 
the propulsion of water and debris through the intestine by attaching to the  mucosa24,25.
Longitudinal studies about the impact of HIV/SIV infection on mucosal tissue-associated microbiome have 
not been performed yet. Moreover, data regarding the mucosa-associated microbiome in the early phase of infec-
tion are rare. Here we studied the composition of the colonic mucosa-associated microbiome within individual 
rhesus macaques before and during the course of SIVmac infection.
Results
Viral replication and  CD4+ t cell depletion in the colonic mucosa of study animals. After cell-
free and/or cell-associated virus transmission, variations in the time to mucosal viral peak were observed in the 
group of study animals, as described  elsewhere26. In three of six animals, highest levels of SIV DNA and/or SIV 
RNA as well as depletion of mucosal  CD4+ T cells were already observed on day 7 after infection, designated 
as time point of ‘mucosal peak viral load’ (Table 1; Fig. 1A, B). In the three other animals, SIV was either not 
detectable in the colonic mucosa at that time or present at only low levels, and therefore that time point was 
designated as ‘before peak viral load’ (Fig. 1A, B). Mucosal virus peak and loss of mucosal  CD4+ T cells in these 
three animals were observed later, on day 14 after inoculation (‘mucosal peak viral load’) (Fig. 1A, B). During 
the chronic phase on day 49 post-infection (‘chronic SIV’),  CD4+ T cells remained at low levels in five animals or 
were restored to some extent in one animal which presented with lowest mucosal SIV DNA levels during both 
infection phases analyzed (animal #2) (Fig. 1A, B). Mucosal SIV RNA and SIV DNA copy numbers during the 
course of infection are given in Table 1.  CD4+ T cell counts in the peripheral blood are shown in Fig. 1C.
characterization of the colonic mucosa‑associated microbiome in chinese rhesus macaques 
housed in single cages. Colonic mucosa-associated microbial communities in single-caged rhesus 
macaques of Chinese origin were assessed in our six animals by 16S rRNA sequencing analysis before SIV infec-
tion. We identified four major microbial phyla representing more than 75% of the colonic mucosa-associated 
microbiome in each animal: Proteobacteria, Firmicutes, Bacteroidetes, and Spirochaetes (Fig. 2A). The most 
dominant bacterium in all six animals belonged to the Gram-negative genus Helicobacter (47.9–85.9%) of the 
phylum Proteobacteria. Analysis of full-length 16S rRNA showed closest matches to Helicobacter macacae. The 
next most abundant bacteria in five animals belonged to the Gram-positive families Lachnospiraceae (13.3–
16.9%) or Ruminococaceae (0.9–1.9%) of the phylum Firmicutes. The second most abundant bacterial genus in 
one animal was Brachyspira (27.1%) from the Gram-negative phylum Spirochaetes.
Impact of SIV infection on colonic mucosa-associated bacteria at the phylum level.  To assess 
the influence of SIV infection on the microbial composition in colonic tissue, we first compared the abundances 
of the four major phyla at pre-infection to different time points after infection. Individual analysis of each of the 
four major phyla revealed notable alterations at the time of mucosal virus load peak. The relative abundances of 
Bacteroidetes and Firmicutes were increased 2- to 5.5-fold and 1.2- to 2.8-fold, respectively at that time (Fig. 2B). 
Bacteroidetes remained elevated during the chronic phase of SIV infection (Fig. 2B). The ratio of Firmicutes to 
Bacteroidetes decreased with disease progression, leading to a 1.5- to 22.5-fold reduction in the chronic phase 
(Fig. 2C), whereas the relative abundances of Proteobacteria and Spirochaetes did not change significantly dur-
ing infection (Fig. 2B).
Table 1.  Mucosal virus loads in the colon of SIV-infected animals. LOD limit of detection, ND not determined 
a Highest SIV DNA and SIV RNA loads in individuals during the course of infection are marked in bold
No
Mucoal SIV DNA (copies/1,000 
cells)a
Mucosal SIV RNA (copies/1,000 
cells)a
d7 d14 d21 d49 d7 d14 d21 d49
1
1.4
 < LOD
 < LOD
447
71.8
755
109
24.3
81.6
35
30.5
29.7
22.1
4.4
8
7.7
35.9
12
ND
0.5
2.7
3.6
3.7
1.4
238
97.7
 < LOD
831
403
93.8
86,500
4,160
1,030
7.8
246
192
1,810
369
173
19.9
186
47.8
ND
29
6.2
25.6
11.0
11.2
2
3
4
5
6
3
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Figure 1.  Mucosal SIV copy numbers and  CD4+ T cells in the colon of SIV-infected animals. (A) 
Cell-associated SIV DNA and RNA copies were quantified longitudinally in colonic tissue before and 
after i.v. infection with SIVmac251. (B)  CD4+ T cells in the colonic lamina propria were quantified by 
immunohistochemical analysis and the proportion  CD45RA- memory phenotype  CD4+ cells within mucosal 
 CD3+ T cells was determined by flow cytometry before and at different stages of SIV infection. (C)  CD4+ T cell 
counts in the peripheral blood were measured in parallel. Mucosal peak viral load was observed on day 7 (black 
symbols) or on day 14 after infection (grey symbols). Day 7-samples of the three animals, in which mucosal 
viral load peaked on day 14, represent ‘before peak viral load’ data. Equivalent data samples were not available 
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SiV infection‑induced alterations in the abundances of mucosa‑associated bacteria below the 
phylum taxonomic level.  Comparisons of the relative abundances of bacteria at the family level as well as 
the genus level revealed overall significant differences between pre-infection and the time of mucosal virus load 
peak (P < 0.0001 for both family and genus) and the chronic phase of SIV infection (P < 0.0001 for both family 
and genus). By contrast, before the colonic viral load peaked in the infected animals, there were no overall sig-
nificant differences at the family or genus level in comparison with pre-infection levels (P = 0.98 and P = 0.41 for 
family and genus, respectively). Among the phylum Bacteroidetes, a shift to increased abundance was notable for 
the class Bacteroidia at the time of mucosal peak viral load (1.3- to ninefold) and during the chronic phase of SIV 
infection (1.5- to 17-fold) (Fig. 3A), while the class Flavobacteria did not change significantly (data not shown). 
At the genus level, Alistipes, which belongs to the family Rikenellaceae of the class Bacteroidia, was elevated in 
five animals (1.6- to 6.5-fold) at the time of mucosal virus peak load and became detectable for the first time in 
animal #4 (Fig. 3A). In addition, abundance of unclassified Bacteroidetes genera was raised 2-to fivefold at that 
time (Fig. 3A).
Among the Firmicutes phylum, no significant changes following SIV infection were observed in the abun-
dance of the three major classes Clostridia, Bacilli, or Negativicutes (data not shown), but the abundance of 
unclassified Firmicutes genera was 1.5- to 90-fold increased at the time of mucosal peak viral load (Fig. 3B). At 
the family level, significant alterations in the abundance of bacteria were observed regarding increase in Rumi-
nococcaceae and Eubacteriaceae families (1.2- to 11.5-fold and 1.7- to 4.2-fold, respectively) (Fig. 3B), whereas 
abundances of Lachnospiraceae and Veillonellaceae did not change (data not shown). At the genus level, signifi-
cant rises were observed for Faecalibacterium and Oscillibacter (1.8- to 7.4-fold and 2.3- to 9.5-fold, respectively) 
from the family Ruminocaccacea at the time of mucosal viral load peak (Fig. 3B). No significant alterations 
during infection were observed among members of the phyla Proteobacteria and Spirochaetes (data not shown).
Diversity in the colonic mucosa-associated microbiome before and after SIV infection.  Taxo-
nomic α-diversity was calculated by the Shannon index that accounts for richness and abundance distribution 
and the Simpson index, a measure of evenness. At the time of acute mucosal virus replication, the Shannon and 
the Simpson diversity index values were up to 2.4-fold and 2.6-fold higher as compared to those before infection 
in five of our six animals (Fig. 3C). The animal without increase at that time (animal #6) showed a comparatively 
high Shannon-diversity even before infection (Fig. 3C). At chronic stage of infection, diversity increased further 
in four animals and was comparable to pre-infection levels in two other animals (Fig. 3C).
Relationships between alterations in the colonic mucosa‑associated microbiome and immune 
parameters. To further investigate whether the observed microbial shifts are related to SIV infection-
induced immune alterations, we performed correlation analyses. For this, we performed longitudinal analysis 
of T cell subsets by flow cytometry and in situ quantitation and, in parallel, of the mucosal cytokine secretion. 
At pre-infection, i.e. under homeostatic conditions, there were no correlations of bacterial phyla with SIV target 
cells. At the time of mucosal peak viremia, under pathological conditions, the increased abundance of Bacteroi-
detes strongly correlated with the extent of mucosal C–C chemokin receptor type 5 (CCR5)+  CD4+ SIV target 
cell loss (Fig. 4A) and was negatively associated with total  CD4+ T cell numbers (Fig. 4B) and  CCR5+  CD4+ T cell 
frequencies (r = 0.6, P = 0.242) in the colonic mucosa. Although correlations did not reach statistical significance 
in this small group of animals, where the minimum r-value of 0.886 is required to yield P-values of ≤ 0.05, these 
trends indicate that the initial SIV infection-associated depletion of mucosal T helper cells might influence the 
proportion of Bacteroidetes within the mucosa-associated microbiome. Consistent with this, the abundance of 
Bacteroidetes at the time of mucosal peak viral load negatively correlated significantly with mucosal secretion 
of the T helper cell cytokine interleukin (IL)-2 and non-significantly with secretion of the type 2 cytokine IL-4 
(Fig. 4C). In addition, after the time of mucosal peak viral load, there was a strong negative correlation between 
subsequent changes in the abundance of Bacteroidetes and the frequency of mucosal  CCR5+ T cells (Fig. 4D). 
Negative correlation between changes of Bacteroidetes and total mucosal  CD4+ T cell numbers was strong dur-
ing the chronic phase of SIV infection (r = 0.66, P = 0.175) but did not reach statistical significance, probably due 
to the low sample size. Collectively, these observations indicate a relationship between the abundance of Bacte-
roidetes and the mucosal SIV-target cell depletion during the course of infection. Abundances of bacteria of the 
phylum Firmicutes, by contrast, did not correlate with mucosal immune parameters.
Relationships of shifts in the mucosa‑associated microbiome with enterocyte damage and 
microbial translocations. To determine whether shifts in the microbiome coincide with the SIV infec-
tion-related mucosal barrier defect and subsequent microbial translocations into the systemic circulation, we 
quantified serum concentrations of intestinal fatty acid-binding protein (I-FABP), which is released into the 
bloodstream upon enterocyte damage and lipopolysaccharide (LPS)-binding protein (LBP), which is produced 
by the immune system in response to the gram-negative bacterial component LPS. As day 7-samples were not 
available for this analysis, samples collected on day 14 post-infection were tested for all animals (‘acute SIV infec-
tion’). Serum levels of I-FABP were increased in four animals with acute SIV infection (1.2- to 5.5-fold) and in 
all six animals during the chronic phase (1.3- to eightfold) (Fig. 5A), which indicates damage to the epithelial 
from animals in which mucosal viral load peaked already on day 7. The chronic phase was analyzed on day 49 
after infection. Horizontal solid lines indicate mean values + /− standard deviations. The dashed horizontal line 
indicates the assay limit of detection. *P < 0.05, ***P < 0.001, ****P < 0.0001. VL viral load.
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Figure 2.  Composition of the colonic mucosa-associated microbiome at the phylum level before and after SIV infection. 
(A) Stacked bar representing the relative abundance of the top four most abundant phyla within colon biopsies in six 
animals before they were infected with SIV. Lower abundant bacteria (Actinobacteria, < 0.2%; Fusobacteria, < 0.2%; and 
Verrucomicrobia, < 0.5% in each animal) and bacteria that were not identified as belonging to any known phylum (mean 
11%, range 3.8—22.6%) were termed ‘Others’. (B) and (C), Relative abundance of the four major phyla (B) and the ratio of 
Firmicutes to Bacteroidetes (C) before and at different stages of SIV infection. Values correspond to the frequency within the 
total bacteria detected within each animal. Mucosal peak viral load was observed on day 7 (black symbols) or day 14 after 
infection (grey symbols). The chronic phase was analyzed on day 49 after infection. Horizontal lines indicate mean values + /− 
standard deviations. *P < 0.05. VL, Viral load.
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Figure 3.  SIV infection-related shifts in the colonic mucosa-associated microbiome at phylum lower taxonomic 
levels and microbial diversity. (A) and (B), Relative abundance of bacteria among the phyla Bacteroidetes 
(A) and Firmicutes (B) before infection, at the time of mucosal viral load peak, and in the chronic phase of 
SIV infection. Values correspond to the frequency within the total bacteria detected within each animal. (C) 
Shannon diversity index and Simpson diversity index were calculated for each animal. Mucosal peak viral load 
was observed on day 7 (black symbols) or day 14 after infection (grey symbols). The chronic phase was analyzed 
on day 49 after infection. Horizontal lines indicate mean values + /− standard deviations. *P < 0.05, **P < 0.01. VL 
viral load.
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barrier that enhances intestinal permeability to microbial products. During the observation period, LBP levels 
increased in five animals (1.2- to 2.6-fold) after infection demonstrating the enhanced translocation of gram-
negative bacterial components into systemic circulation (Fig.  5A). Early changes in I-FABP and LBP serum 
strongly correlated with abundances of Bacteroidetes (Fig. 5B) but not with those of Firmicutes or bacteria of 
other phyla (data not shown). Correlations of absolute levels of I-FABP and LBP with abundances of Bacteroi-
detes at the time of mucosal peak viral load (r = 0.6, P = 0.242 and r = 0.83, P = 0.058, respectively) were strong but 
did not reach statistical correlation due to sample size limitation.
In addition, there was a strong but non-significant correlation between the percent change in I-FABP levels 
from pre-infection to the time of chronic infection and concomitant percent change in the abundance of Bacteroi-
detes (r = 0.71, P = 0.136). These observations indicate that components or products of the phylum Bacteroidetes 
might affect the epithelial barrier integrity.
colonic mucosa‑associated content of microbial products. Bacterial components and fermenta-
tion end products have an impact on immune regulation and host metabolism. To investigate the influence of 
SIV infection on the release of such microbial products in the colon, we quantified the Gram-negative cell wall 
component LPS and the short chain fatty acids (SCFA) acetate and butyrate. At the time of acute mucosal virus 
replication, mucosa-associated contents of LPS and acetate were each increased in five out of six animals (2- to 
40-fold and 1.5- to 69-fold) (Fig. 6A). In chronic infection, LPS levels remained higher as compared to those 
at pre-infection (Fig. 6A). The content of butyrate, by contrast, did not change significantly after SV infection 
(data not shown). There was a trend towards a strong correlation between the early changes in LPS and acetate 
levels and a very strong correlation between the levels of LPS and acetate in the chronic phase of SIV infection 
(Fig. 6B), which implies a causal or functional relation between mucosa-associated Gram-negative bacteria and 
acetate production in SIV infection. Together, these data indicate that SIV infection-associated shifts in the 
colonic microbiome may have metabolic effects.
Figure 4.  Associations of SIV infection-related shift towards Bacteroidetes with mucosal  CD4+ T cell counts 
and cytokine secretion. Correlations of abundances of Bacteroidetes at the time mucosal peak viral load with (A) 
initial SIV infection-associated changes of frequencies of  CCR5+  CD4+ T cells (determined by flow cytometric 
analysis) and (B) total  CD4+ T cell numbers in the colonic mucosa (quantified by in situ immunostaining) and 
(C) with the levels of mucosal secretion of IL-2 (black symbols) and IL-4 (open symbols). Values, depicted as 
percent change in immune parameters, were calculated for each animal as change between pre-infection levels 
and those at the time of mucosal peak viral load. (D) Correlations between the changes in mucosal  CCR5+  CD4+ 
T cell frequencies and the changes in abundances of Bacteroidetes during the chronic phase of SIV infection. 
Percent changes were calculated between levels at peak viremia and levels at the chronic stage of infection.
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Discussion
In this longitudinal study of the microbiome, we have chosen biopsy tissue over stool samples for analysis to 
identify bacteria that are closely associated with the mucosal epithelial layer, and therefore are more likely to 
interact with mucosal cells and to translocate in the event of epithelial damage. Moreover, mucosal tissue sam-
ples were collected with only mild colonic cleansing preparation to reduce the potentially confounding effects 
of bowel  preparation27.
One major finding is the shift towards Gram-negative Bacteroidetes in the colonic mucosa-adherent micro-
biome, including members of the Bacteroidia class, that was first observed at the time of mucosal virus peak, 
was maintained up to the chronic phase, and was associated with the extent of colonic  CD4+ T cell depletion. 
Even though this association was not statistically significant at the time of mucosal peak viral load, probably 
due to the small number of animals, our observation is consistent with the previously observed trend toward 
a negative association between Bacteroides abundance and mucosal  CD4+ T cells in the colon of HIV-infected 
 persons11. Virus-induced mucosal immune defects might therefore play an essential role in shaping the tissue-
associated microbial composition. Moreover, in spite of limitations due to small sample size, our data allow to 
speculate about a possible role of Bacteroidetes in the modulation of the epithelial barrier integrity, as their abun-
dances were strongly associated with the rates of enterocyte damage. Interestingly, human diseases thought to be 
influenced by members of the phylum Bacteroidetes such as inflammatory HIV-related diseases bowel disease, 
colorectal cancers, and autoimmune disorders are all associated with impaired intestinal barrier integrity and 
enhanced microbial  translocation28–32. In future studies, it would therefore be interesting to investigate whether 
Figure 5.  SIV infection-related impact on enterocyte damage in the colon. (A) Serum concentrations of 
I-FABP, a sensitive biomarker for enterocyte damage, and the microbial translocation biomarker LBP before 
infection and on days 14 and 49 after SIV infection (acute and chronic stage of infection). Mucosal peak viral 
load was observed on day 7 (black symbols) or day 14 after infection (grey symbols). The chronic phase was 
analyzed on day 49 after infection. (B) Correlations of abundances of Bacteroidetes with initial SIV infection-
associated changes in I-FABP and LBP serum levels. Values, depicted as percent change in I-FABP or LBP, were 
calculated for each animal as change between pre-infection levels and those at the time of mucosal peak viral 
load. *P < 0.05.
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specific components or products of Bacteroidetes may function as tissue disturbing factors, thereby increasing 
epithelial permeability and microbial translocations.
In addition, the abundance of Gram-positive Firmicutes and in particular bacteria of the Clostridia families 
Ruminococcaceae and Eubacteriaceae were increased at the time of acute mucosal virus replication. In contrast 
to the elevation of Bacteroidetes, these changes in microbial composition were not associated with mucosal 
immune parameters indicating that different mechanisms are involved in the SIV infection-related alteration 
of different bacterial phyla.
However, both bacterial phyla produce SCFAs from indigestible carbohydrates that reach the colon, with 
Firmicutes being the main butyrate producers and Bacteroidetes producing mainly acetate and propionate. In 
healthy condition, SCFAs are important energy sources for enterocytes, modulate intestinal processes such as 
electrolyte and water absorption and regulate immune  responses33. Detrimental effects of tissue SCFAs including 
inhibition of effector functions and delay in wound repair have been described in infectious conditions and in 
the event of mucosal  injury34,35. Progressive decrease in the ratio of Firmicutes to Bacteroidetes that we observed 
in this study may change SCFA production in the colon, thereby inducing metabolic alterations fostering disease 
 progression36. Interestingly, a decrease in the Firmicutes/Bacteroidetes ratio has been shown to be associated 
with substantial weight  loss37, a phenomenon that is often observed in HIV-infected patients during the course 
of infection and has often been considered as an unfavorable prognostic factor of  survival38,39. We found in our 
SIV-infected animals an association of acetate production with increasing contents of LPS in colonic tissue, 
which indicates that Gram-negative bacteria can have metabolic effects in SIV infection. According to a previous 
study, acetate enhances HIV integration into the genome of host cells by histone  modifications40. Consequently, 
high colonic acetate concentrations at the time of mucosal peak viral load might enhance viral integration and 
Figure 6.  SIV infection-related impact on microbial components in the colonic mucosa. (A) Colonic mucosa-
associated contents of LPS and acetate before and at different stages of SIV infection were quantified in tissue 
culture supernatants. Decay of bacteria and release of bacterial components into supernatant was achieved 
by antibiotics. Mucosal peak viral load was observed on day 7 (black symbols) or day 14 after infection (grey 
symbols). The chronic phase was analyzed on day 49 after infection. (B) Correlations between the initial changes 
of both bacterial components and between their levels at chronic stage of SIV infection. Values, depicted as 
percent change in LPS or acetate, were calculated for each animal as change between pre-infection levels and 
those at the time of mucosal peak viral load. *P < 0.05.
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replication. Moreover, SCFAs have been shown to regulate colonic homeostasis by promoting regulatory T cell 
(Treg)  differentiation41. Thus, alterations in the mucosa-associated microbiome composition might contribute 
to the previously described accumulation of colonic Treg in SIV  infection42.
After infection, we additionally observed a trend toward a greater overall diversity of the tissue-associated 
microbiome with higher richness as measured by the Shannon diversity and evenness as measured by the Simp-
son diversity. This suggests that SIV infection-related changes in the colonic mucosa may facilitate the growth 
of diverse bacterial strains, including those of the phylum Bacteroidetes. By contrast to our tissue-associated 
findings, longitudinal studies of fecal microbiota showed reduced diversity or unchanged community composi-
tion during acute SIV  infection20,21. Thus, the effects of SIV infection on the mucosa-associated microflora may 
differ from those on fecal microflora. Differences between the mucosa-associated and the luminal microbiome 
have previously been shown in healthy  adults25,43,44.
The dominant genus within the mucosa-associated microbiome in the colon of our Chinese rhesus macaques 
was Helicobacter of the phylum Proteobacteria, which is in agreement with a previous study on healthy rhesus 
 macaques45. In humans, by contrast, organisms from the phylum Proteobacteria are a minor population or absent 
in the  colon11,27,43. High abundance of mucosa-adherent Helicobacter at this site may therefore be a distinctive 
feature of housed rhesus macaques. Colonization may result from early microbial exposures or through cross-
infections via fomites by the fecal–oral route of transmission. Interestingly, persistent colonization of Helicobacter 
species has been demonstrated in the intestine of single-caged rhesus  macaques46,47 but not in free living gorillas, 
chimpanzees, and  bonobos48, which indicates that the host-environment shapes distribution.
In summary, our results suggest that alterations in the colonic mucosa-associated microbiome are induced 
at the time of acute mucosal SIV replication and are partly associated with mucosal  CD4+ T cell depletion. 
Alterations in colonic microbial composition were dominated by an increase of LPS-containing and SCFA-
producing bacteria of the Gram-negative phylum Bacteroidetes, which may contribute to inflammatory and 
metabolic disease in SIV/HIV infection. Moreover, association of the compositional shift towards Bacteroidetes 
with increasing rates of enterocyte damage suggests that mucosa-associated members of this phylum might 
contribute to the epithelial barrier defect and microbial translocations in SIV infection. As these pathological 
events are leading to HIV-related diseases in untreated and treated patients, that aspect could be important for 
future studies on therapeutic interventions.
Methods
experimental SiV infection. Purpose-bred adult rhesus macaques (Macaca mulatta) of Chinese origin 
were housed at the German Primate Center (DPZ) according to the German Animal Welfare Act which complies 
with the European Union guidelines on the use of NHPs for biomedical research and the Weatherall report. The 
study was approved by the Lower Saxony State Office for Consumer Protection and Food Safety and performed 
with the project license 509.42502/08-04.03. Six animals were infected intravenously (i.v.) with cell-free SIV-
mac251. Three of those animals were additionally inoculated i.v. with cell-associated SIVmac251, as described 
 elsewhere26. Transmission of cell-associated virus in these animals accelerated the initial virus  dissemination26. 
Colonic biopsies were collected seven days before and at several time points after infection under combined 
ketamine, xylazine and atropine anaesthesia as previously  described26,42. One day before colonoscopy, animals 
received Bisacodyl orally in water (1.2 – 2.7 mg/kg; Dulcolax, Sanofi-Aventis Germany) to stimulate gut motil-
ity. None of the animals developed acquired immunodeficiency syndrome-like disease during the observation 
period of 49 days. Plasma viral loads are given  elsewhere26.
Quantitation of viral DNA and RNA in mucosal tissue.  DNA and RNA were extracted from colonic 
biopsy specimens with the use of the Allprep DNA/RNA Mini kit (Qiagen) according to the manufacturer’s 
protocol. Viral DNA or viral RNA were quantified by Taqman based real-time PCR (ABI-Prism 7500 Real-Time 
PCR system, Applied Biosystems) as described  before26,42.
Preparation  and  sequencing of  16S  rRNA amplicon  libraries.  For phylogenetic analysis the V4 
region of 16S rRNA genes was amplified from colon DNA using the Illumina overhang-adapter-sequence cou-
pled primers 515F (5′GTG CCA GCMGCC GCG GTAA3′) and 806R (5′GGA CTA CHVG GGT WTC TAAT3′)49 as 
described in the Illumina “16S Metagenomic Sequencing Library Preparation” instructions with 30 amplifica-
tion cycles. Amplicon size (390 bp including adaptor sequences) and quality was checked for each sample by 
use of Agilent Bioanalyzer DNA1000 chips. The dual-indexing PCR was performed as described in the above-
mentioned manual. Quality of the final libraries was again checked on Agilent Bioanalyzer DNA1000 chips. 
Each individual library was adjusted to a DNA concentration of 4 nM. DNA concentration was measured apply-
ing Qubit assay kits (Invitrogen). The libraries were pooled, spiked with a PhiX control as recommended in the 
Illumina “16S Metagenomic Sequencing Library Preparation” protocol and diluted to a DNA concentration of 
3 pM. Paired-end sequencing was performed on an Illumina MiSeq machine using a MiSeq Reagent Kit v3 for 
600 cycles following manufacturer’s instructions. The resulting fastq raw data files were used for data analysis. 
These raw data are available in EMBL-EBI SRA under the Bioproject ID PRJEB31033.
High-throughput 16S rRNA gene amplicon analyses.  Adapter and primer trimming of amplicon 
raw reads were performed through an inhouse  pipeline50. Based on a pipeline including FLASH v.1.2.1151, USE-
ARCH v.1052,  UPARSE53, and the Ribosomal Database Project (RDP) classifier v.2.954, all amplicons datasets 
were processed as recently  described55–58 (For details see: https ://www.drive 5.com/usear ch/manua l10/ex_miseq 
.html). In brief, all sequences that were not merged by FLASH (default settings with modifications [M = 300]), 
sequences with > 1 N (ambiguous base) in the sequence read and expected errors > 0.5 were discarded. Filtered 
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datasets were processed, operational taxonomic units (OTUs) were clustered using USEARCH and taxonomi-
cally classified with the RDP classifier in 16S modus (confidence value > 0.8). Finally, obtained raw reads were 
mapped back onto the OTU sequences to get quantitative assignments. Normalized calculation of the Shannon 
index and the Simpson index was performed by an inhouse perl script.
in situ quantitation of mucosal t cells. Immunostaining on paraffin sections was performed as previ-
ously  described1–3,42. The primary antibodies was mouse anti-CD4 (clone 1F6; Novocastra, Newcastle, UK). For 
detection, the streptavidin–alkaline phosphatase kit with Fast Red as chromogen (Dako) was used according to 
the manufacturer’s instructions. Nuclei were counterstained with hematoxylin (Merck, Darmstadt, Germany). 
Positive cells within the lamina propria were quantified in colonic tissues per high-power field (hpf; 0.237mm2), 
and 10 hpf were averaged in each  case1–3,42.
Mucosal cell isolation and flow cytometric analysis.  Mucosal mononuclear cells were isolated from 
colonic biopsy specimens by collagenase type II (Sigma, Hamburg, Germany) digestion as described  previously2,3. 
The following antibodies were used for phenotypic analysis: anti-CD3-allophycocyanin (APC), anti-CD3-peri-
dinin chlorophyll protein Cy5.5 (PerCPCy5.5; both clone SP34; BD Biosciences), anti-CD4-PerCPCy5.5, anti-
CD4-APC (both L200; BD), anti-CD8-phycoerythrin (PE), anti-CD8-fluorescein (FITC; both DK25; Dako), 
anti-CD45RA-FITC (ALB11; Beckman Coulter), and anti-CCR5-PE (3A9; BD). Lymphocytes were gated on the 
basis of characteristic forward and side scatter properties.  CD4+ T cells were identified by co-expression of CD3 
and lack of CD8 expression and memory  CD4+ T cells were identified by lack of CD45RA expression on  CD4+ 
T cells. The total number of analyzed colonic cells was between 360,000 and 550,000 and cells in the  CD3+ T 
cell gate consisted of 14,000 – 44,000 colonic cells.  CD4+ T cell counts in fresh whole blood were quantified by 
the use of Trucount Tubes (BD) according to the manufacturer’s instructions. Data were acquired on the FACS 
Calibur (BD) and analyzed with FlowJo software version 8.8.4. (BD).
Short‑term colonic tissue culture and quantitation of mucosal cytokine secretion and micro‑
bial products. Short-term culture supernatants of colonic biopsy specimens were prepared as described 
 before59. Briefly, biopsy specimens were washed, weighted, and incubated in 200 µL of fetal calf serum-free 
Roswell Park Memorial Institute 1640 medium (Gibco-BRL) containing 100 U/mL penicillin, 100 µg/mL strep-
tomycin, and 2.5 µg/mL amphotericin (Seromed Biochrom KG) for 48 h at 37 °C in a humidified 5%  CO2/70% 
 O2 air atmosphere. Decay of bacteria with release of bacterial components was achieved by culture media sup-
plemented with antibiotics. The contents of LPS, acetate, and butyrate were quantified with Enzyme-linked 
Immunosorbent Assays for LPS or Butyric Acid (both Cloud-Clone Corp., USA) and an Acetate Colorimetric 
Assay (Sigma Aldrich, USA) according to the manufacturer’s protocols. IL-2 and IL-4 were quantified in the 
supernatants with cytometric bead arrays (BD) according to the manufacturer’s protocol.
Quantitation of biomarkers of enterocyte damage and microbial translocation. Commercially 
available assay kits were used according to manufacturer’s protocols to quantify I-FABP and LBP (both Hycult 
Biotech, Uden, The Netherlands) in serum.
Statistical analysis. Data were analyzed using the paired t-test, if they passed the Kolmogorov–Smirnov 
normality test or the Wilcoxon matched-pairs signed rank test. Correlations and statistical significance were 
determined by the Spearman rank correlation test. All data were statistically analyzed with Prism software ver-
sion 5.0 (Graph Pad Inc., La Jolla, CA).
Data availability
The sequence data generated and analysed during the current study are available in the EMBL-EBI SRA reposi-
tory under the Bioproject ID PRJEB31033.
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